A new imaging technique developed by engineers at Washington University in St. Louis can give scientists a much closer look at fibril assemblies, stacks of peptides like amyloid beta, most notably associated with Alzheimer’s disease.
Abbott’s Nadim Geloo on Triclip’s US launch, Edwards competition
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Abbott secured Food and Drug Administration approval
April 12, 2024